Verrica Pharmaceuticals Inc.VRCANASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-239.53%
Near historical average
Average (34q)
-262.97%
Historical baseline
Range
High:102.09%
Low:-7107.28%
Volatility
-2741.5%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -239.53% |
| Q2 2025 | 102.09% |
| Q1 2025 | 57.26% |
| Q4 2024 | 50.61% |
| Q3 2024 | -31.89% |
| Q2 2024 | 15.33% |
| Q1 2024 | 17.70% |
| Q4 2023 | 1.30% |
| Q3 2023 | -124.78% |
| Q2 2023 | -56.28% |
| Q1 2023 | -6.10% |
| Q4 2022 | -7107.28% |
| Q3 2022 | 100.56% |
| Q2 2022 | -20.05% |
| Q1 2022 | 11.22% |
| Q4 2021 | 25.64% |
| Q3 2021 | -8.94% |
| Q2 2021 | -1070.60% |
| Q1 2021 | 92.94% |
| Q4 2020 | -23.39% |
| Q3 2020 | -11.34% |
| Q2 2020 | 4.21% |
| Q1 2020 | -28.39% |
| Q4 2019 | -25.26% |
| Q3 2019 | 13.07% |
| Q2 2019 | 6.46% |
| Q1 2019 | 1.35% |
| Q4 2018 | -28.31% |
| Q3 2018 | 74.29% |
| Q2 2018 | -42.68% |
| Q1 2018 | -801.14% |
| Q4 2017 | -35.94% |
| Q3 2017 | -24.13% |
| Q2 2017 | -92.11% |
| Q1 2017 | 0.00% |